Past Liver Center Seminars


Date Speaker Title


Emma R. Andersson, PhD
Assistant Professor and Director, Virus Technologies Core Facility Karolinska Institute; Visiting Assistant Professor of Medicine (Digestive Diseases), Yale School of Medicine

“A murine Jagged1 missense mutation recapitulates Alagille syndrome and reveals novel disease-driving mechanisms”


Ludovic Vallier, PhD
Professor of Regenerative Medicine, University of Cambridge and Senior Faculty, Welcome Trust Sanger Institute

“Pluripotent stem cells and organoids to study liver diseases”


Laura E. Nagy, PhD
Professor of Molecular Medicine and Director, Center for Liver Disease Research Cleveland Clinic Foundation

“MicroRNA profiling of hepatic microphages in models of alcoholic liver disease”
11/28/2017 Bernd Schnabl, MD
Associate Professor in Gastroenterology
University of California, San Diego
“Gut microbiota and chronic liver disease”


Juan Saez, PhD
Pontifical Catholic University of Chile, Santiago, Chile

“Identifying new molecular targets to reduce inflammation and learning on their role in tissue dysfunction of chronic diseases ”
2/6/2018 Thomas Anthony Wynn, PhD
Vice President Discovery, Inflammation and Immunology Research, Pfizer, Inc.
“The immunology of tissue repair and fibrosis”
3/6/2018 David E. Cohen, MD, PhD
Vincent Astor Distinguished Professor of Medicine
Chief, Division of Gastroenterology and Hepatology
Joan & Sanford I. Weill Department of Medicine
Weill Cornell Medicine
“Starting to Identify New Molecular Targets in the Management of Non-Alcoholic Fatty Liver Disease”
4/3/2018 Drew Feranchak, MD
Willis C. Maddrey, MD, Distinguished Professor of Liver Disease
Associate Professor of Pediatrics
Chief, Division of Pediatric Gastroenterology, Hepatology, & Nutrition
University of Texas Southwestern Medical Center

“Targeting Cholangiocyte Ion Channels for the treatment of Cholestasis”


Robert E. Schwartz, MD, PhD 
Assistant Professor of Medicine & Physiology, Biophysics, & Systems Biology
Director of Laboratory Stem Cell Model Development
Weill Cornell College of Medicine

“Modeling human liver disease using engineered liver tissue”

6/5/2018 Rosario Rizzuto, MD, PhD
Chancellor (Magnificent Rector)
University of Padova, Padova, Italy

“Mitochondrial calcium and potassium transport in cell life and death”

6/12/2018 Paul Kubes, PhD
Professor, Departments of Physiology & Pharmacology, Medicine, and Microbiology, Immunology and Infectious Diseases
University of Calgary

“Imaging sterile inflammation and infections”


Date Speaker Title


Huma Cheema, MBBS, MRCP
Director, Pediatric Gastroenterology & Hepatology Division
Children’s Hospital Lahore

“Rare Pediatric Liver Diseases in Pakistan – Challenges and Opportunities”


Martin Kriegel, MD
Assistant Professor of Immunobiology
Assistant Professor of Medicine (Rheumatology)
Yale School of Medicine
“Gut Commensal Translocation to the Liver in Autoimmunity”


Gavin Arteel, PhD, FAASLD
Professor and Distinguished University Scholar
Associate Chair for Research
Department of Pharmacology and Toxicology
University of Louisville Health Sciences Center

“Transitional Changes to the Hepatic ‘Matrisome’ in the Development of Inflammatory Liver Injury.”
12/6/2016 Amir Qamar, MD
Senior Staff Hepatologist
Medical Director, Liver Transplant Program
Lahey Hospital and Medical Center
“Maintaining Wellness of the Liver Transplant Recipient”


Theo Heller, MD
Chief, Clinical Research Section – Translational Hepatology Unit, Liver Diseases Branch
National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK)

“The Dark Side of the Moon: A Different Perspective of Hepatitis C.”
2/14/2017 Gerald Shulman, MD, PhD, FACP, MACE
George R. Cowgill Professor of Medicine (Endocrinology) and Professor of Cellular & Molecular Physiology
Investigator, Howard Hughes Medical Institute
Co-Director, Yale Diabetes Research Center
Director, Yale Mouse Metabolic Phenotyping Center
“A Novel Treatment Approach for NASH”
3/7/2017 Vishwa Deep Dixit, DVM, PhD
Professor of Comparative Medicine and of Immunobiology
Yale School of Medicine
“Inflammation of Age.”
4/4/2017 Holger Willenbring, MD, PhD
Professor of Surgery
Member, Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research
Associate Director, Liver Center
University of California San Francisco
“Spontaneous and Induced Transdifferentiation in the Liver.”


Date Speaker Title


Ulrich Beuers, MD
Professor of Gastroenterology & Hepatology
The Academic Medical Center

"The Potential Role of the Biliary HCO3- Umbrella in Human Cholangiopathies"


Joseph Lim, MD
Associate Professor of Medicine (Digestive Diseases)
Director, Yale Viral Hepatitis Program
Yale School of Medicine
“The Cascade of Care for Hepatitis B and C: Opportunities and Challenges”


Jeff Geschwind, MD
Professor of Radiology and Chair
Department of Diagnostic Radiology
Yale University School of Medicine
Chief, Department of Radiology
Yale-New Haven Hospital
“Non-Surgical Treatment of HCC”


Elizabeth Verna, MD

Assistant Professor of Medicine
New York Presbyterian/Columbia University Medical Center

“The Role of Bacterial Translocation and the Intestinal Microbiome in Liver Transplant Recipients.”


Augusto Villanueva, MD, PhD
Assistant Professor of Medicine (Liver Diseases, Hematology, and Medical Oncology)
Mount Sinai Hospital
“New Trends in Molecular Stratification of Liver Cancer Patients.”


Christopher Bowlus, MD

Professor of Medicine and Acting Chief, Division of Gastroenterology & Hepatology
UC Davis Medical Group, Elk Grove
“The Known and Unknowable Unknowns of Primary Sclerosing Cholangitis.”


Silvia Vilarinho, MD, PhD

Instructor in Medicine (Digestive Diseases)
Yale School of Medicine

“Genetics of Idiopathic Non-Cirrhotic Portal Hypertension: From Families to Genes.”


Vincenzo Mazzaferro, MD

Director, Gastrointestinal and Hepato-Pancreatic and Liver Transplantation Unit
Vice-Scientific Director for Clinical Research
Instituto Nazionale dei Tumori of Milan

“Liver Transplantation for HCC: An Unfinished Product.”


Alfica Sehgal, PhD
Principal Scientist

Patrick Haslett, MD
Senior Medical Director

Kevin Fitzgerald, PhD
Senior Research Biotechnology Executive

Pushkal Garg, MD
Senior Vice President, Clinical Development
Anylam Pharmaceuticals
“RNAi- Successful Translation from Bench to Clinic”


Binita Kamath, MDDChir, MRCP, MTR

Staff Physician, Division of Gastroenterology, Hepatology, and Nutrition
The Hospital for Sick Children
Associate Scientist, Research Institute
Associate Professor, University of Toronto

"Alagille Syndrome: Have Research Advances Impacted Clinical Care?”